Cargando…
Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas
BACKGROUND: Procaspase-3 (PC-3) is overexpressed in various tumor types, including gliomas. Targeted PC-3 activation combined with chemotherapy is a novel strategy for treating patients with high-grade gliomas, with promising preclinical activity. This study aimed to define safety and tolerability o...
Autores principales: | Holdhoff, Matthias, Nicholas, M Kelly, Peterson, Richard A, Maraka, Stefania, Liu, Li C, Fischer, James H, Wefel, Jeffrey S, Fan, Timothy M, Vannorsdall, Tracy, Russell, Meredith, Iacoboni, Michaella, Tarasow, Theodore M, Hergenrother, Paul J, Dudek, Arkadiusz Z, Danciu, Oana C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406430/ https://www.ncbi.nlm.nih.gov/pubmed/37554223 http://dx.doi.org/10.1093/noajnl/vdad087 |
Ejemplares similares
-
Immunohistochemical Characterization of Procaspase-3 Overexpression as a Druggable Target With PAC-1, a Procaspase-3 Activator, in Canine and Human Brain Cancers
por: Schlein, Lisa J., et al.
Publicado: (2019) -
Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patients
por: Joshi, Avadhut D., et al.
Publicado: (2017) -
Small-Molecule Procaspase-3 Activation Sensitizes
Cancer to Treatment with Diverse Chemotherapeutics
por: Botham, Rachel C., et al.
Publicado: (2016) -
Dual Small-Molecule
Targeting of Procaspase-3
Dramatically Enhances Zymogen Activation and Anticancer Activity
por: Botham, Rachel C., et al.
Publicado: (2014) -
Photofrin binds to procaspase-3 and mediates photodynamic treatment-triggered methionine oxidation and inactivation of procaspase-3
por: Hsieh, Y-J, et al.
Publicado: (2012)